Foster Dykema Cabot & Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Hold |
4,526
| – | – | 0.02% | 103 |
|
|
2025
Q1 | $319K | Buy |
4,526
+166
| +4% | +$11.7K | 0.03% | 97 |
|
|
2024
Q4 | $375K | Sell |
4,360
-28
| -0.6% | -$2.41K | 0.03% | 92 |
|
|
2024
Q3 | $522K | Buy |
4,388
+1,298
| +42% | +$155K | 0.04% | 74 |
|
|
2024
Q2 | $441K | Hold |
3,090
| – | – | 0.04% | 69 |
|
|
2024
Q1 | $400K | Hold |
3,090
| – | – | 0.04% | 70 |
|
|
2023
Q4 | $320K | Buy |
+3,090
| New | +$320K | 0.03% | 73 |
|